- Global Pharma News & Resources

Luminex Corporation Declares First Quarter Cash Dividend

Luminex Corporation Declares First Quarter Cash Dividend

PR Newswire

AUSTIN, Texas, Feb. 8, 2019

AUSTIN, Texas, Feb. 8, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the first quarter of 2019 of $0.06 per share of common stock payable on April 11, 2019 to stockholders of record as of the close of business March 21, 2019.

About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at

Harriss Currie
Senior Vice President and Chief Financial Officer

David Carey
Investor Relations
Lazar Partners


View original content to download multimedia:

SOURCE Luminex Corporation

Editor Details

Last Updated: 08-Feb-2019